Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021238-26-000012

Chief Discovery Officer acquired 6,020 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kreitzer Anatol · Chief Discovery Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-17 Grant or award : show line 1 in the form +6,020 180,926 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-17 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +24,455 24,455 D
Loading xslF345X06/form4-08192026_060813.xml…